Anastrozole Tablet, Coated
Product Images NDC 71335-3145

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 71335-3145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 01)

Chemical structure diagram of anastrozole, showing the arrangement of nitrogen atoms in a triazole ring, a benzene ring, and attached cyano and methyl groups.*

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 02)

A line graph showing disease-free survival over time in months for patients treated with anastrozole and tamoxifen. The y-axis represents the proportion of patients alive and disease-free, and the x-axis represents disease-free survival in months up to 90 months. The graph includes a legend differentiating randomized treatment lines: a dashed line for anastrozole and a solid line for tamoxifen. Patient numbers at risk for both treatments are listed below the graph over time.*

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 03)

A survival curve chart depicting disease-free survival in months on the x-axis against the proportion alive and disease-free on the y-axis. Two lines compare randomized treatment groups: anastrozole (dashed line) and tamoxifen (solid line). Included below the graph is a table showing the number of patients at risk over time for each treatment group.*

FDA Label Image

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 04)

Kaplan-Meier curve illustrating proportion event-free over time in months for two randomized treatments: anastrozole and tamoxifen. The chart shows event-free survival decreasing over 120 months, with corresponding numbers of patients at risk listed below the time axis.*

FDA Label Image

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 05)

A Kaplan-Meier curve showing proportion event free over time (months) comparing randomized treatments Anastrozole and Tamoxifen. Below the graph, a table lists the number of patients at risk at various time points from 0 to 120 months for each treatment group.*

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 06)

A line chart showing the proportion of patients not progressing over time in months compared between two randomized treatments: anastrozole (solid line) and tamoxifen (dashed line). The y-axis represents the proportion not progressing from 0.0 to 1.0, and the x-axis shows time to progression in months up to 42. Below the graph, the number of patients at risk is displayed for each treatment at selected months.*

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 07)

A Kaplan-Meier curve showing the proportion of patients not progressing over time (months) comparing randomized treatment with Anastrozole versus Tamoxifen. The x-axis represents time to progression in months, and the y-axis represents the proportion not progressing. Numbers at risk for each treatment group are shown below the x-axis for selected time points.*

FDA Label Image

Label (Lbl713353145)

Anastrozole Tablets USP 1 mg coated tablets, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Zydus Lifesciences Ltd. The label indicates a package size of 30 tablets and includes barcodes, QR codes for professional information, storage instructions, and a note that the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.